Marissa Shrader
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 4
- Vascular Tumors and Angiosarcomas 1
-
- Ovarian cancer diagnosis and treatment 2
- Co-authors
- David J. McConkeyColin P. DinneyLaura M. LashingerLiana AdamMaria Simona PinoMenashe Bar‐EliSimon A. WilliamsKeyi Zhu
- Journals
- Cancer Research (3 papers)Genome (2 papers)Molecular Cancer Therapeutics (1 paper)Cancer Biology & Therapy (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Marissa Shrader
14 papers receiving 604 citations
Peers
Comparison fields: 5 of 67
- Oncology 292
- Cancer Research 158
- Molecular Biology 380
- Pulmonary and Respiratory Medicine 134
- Biotechnology 30
Countries citing papers authored by Marissa Shrader
This map shows the geographic impact of Marissa Shrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marissa Shrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marissa Shrader more than expected).
Fields of papers citing papers by Marissa Shrader
This network shows the impact of papers produced by Marissa Shrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marissa Shrader. The network helps show where Marissa Shrader may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marissa Shrader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 33 | |
| 2 | 2010 | 1 | |
| 3 | 2010 | 4 | |
| 4 | 2009 | 1 | |
| 5 | 2009 | 8 | |
| 6 | 2008 | 89 | |
| 7 | 2007 | 56 | |
| 8 | 2007 | 74 | |
| 9 | 2006 | 45 | |
| 10 | 2005 | 94 | |
| 11 | 2005 | 1 | |
| 12 | 2002 | 124 | |
| 13 | 1998 | 12 | |
| 14 | 1998 | 1 | |
| 15 | Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. | 1995 | 85 |
About Marissa Shrader
Marissa Shrader is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 628 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cell death mechanisms and regulation (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Oncology (292 citations), Cancer Research (158 citations), Molecular Biology (380 citations), Pulmonary and Respiratory Medicine (134 citations) and Biotechnology (30 citations). Marissa Shrader has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include David J. McConkey, Colin P. Dinney, Laura M. Lashinger, Liana Adam, Maria Simona Pino, Menashe Bar‐Eli, Simon A. Williams, Keyi Zhu, Matthew T. Harbison and Lee M. Ellis. Their work appears in journals such as Cancer Research, Genome, Molecular Cancer Therapeutics, Cancer Biology & Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.